Member Log-in

I forgot my password

Not a Member? Register

Tackling the Triple Transition in Global Health Procurement


Global health procurement needs are evolving rapidly as countries face a triple transition:

First, with income levels rising, low- and middle-income countries face the prospect of a transition from donor aid. Health products procurement, especially in low-income countries, remains heavily reliant on donors; making up for lost financing following donor exit will stretch already-strained national health budgets. Many low-income and lower-middle-income countries also have limited experience and capacity in procurement-related functions.

Second, low- and middle-income countries face an epidemiological transition. As countries become wealthier, disease burdens shift from infectious to noncommunicable diseases such as cardiovascular disease, cancer, and diabetes. To meet their citizens’ evolving health needs, governments will need to purchase and make available a very different set of health products from those procured today.

Third, countries face a transition in health system organization as they move away from siloed disease-specific programs and out-of-pocket spending toward universal health coverage. As more governments commit to protecting their citizens against catastrophic health spending, national or subnational procurement processes will be a cornerstone of equitable and universal access to health products. Achieving universal health coverage within tight budgets will require national governments and their global health partners to make procurement decisions that deliver the most value for money.

Key insights on health product markets in low- and middle-income countries

Key insight 1: In low- and middle-income countries, prices for basic generic medicines can vary and far exceed wealthy-country prices.

Key insight 2: Low- and middle-income countries disproportionately purchase expensive branded generic drugs rather than cheaper unbranded generics.

Read the full report here.

You May Also Like

LNCT Webinar Resources: Assessing Bottlenecks to Adequate and Predictable Vaccine Financing

On June 23, 2020, LNCT held a webinar, Assessing Bottlenecks to Adequate and Predictable Vaccine Financing. Diagnosing the root cause of constraints affecting the adequacy and predictability of vaccine financing is an important part of the Gavi transition. The World Bank created a tool that aims to help country counterparts pinpoint the root cause of … Continued

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand

Background: The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a country with established governance structures and accountable decision-making processes for immunization policy. While the existing literature informs vaccine adoption … Continued

Sustaining Pneumococcal Vaccination After Transitioning from Gavi Support: A Modelling and Cost-effectiveness Study in Kenya

Background In 2009, Gavi, the World Bank, and donors launched the pneumococcal Advance Market Commitment, which helped countries access more affordable pneumococcal vaccines. As many low-income countries begin to reach the threshold at which countries transition from Gavi support to self-financing (3-year average gross national income per capita of US$1580), they will need to consider … Continued

Choose a Language